Showing posts with label Approved. Show all posts
Showing posts with label Approved. Show all posts
Saturday, June 13, 2026

Eylea HD (aflibercept) Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

›
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food and Drug Administration (FDA) approval of Eylea HD (aflibercept) Inje...
Monday, June 1, 2026

Bictegravir and lenacapavir: What is it and is it FDA approved?

›
In continuation of my update on  lenacapavir   lenacapavir   Bictegravir Bictegravir plus lenacapavir (BIC/LEN) is an integrase strand trans...
Wednesday, August 21, 2024

Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA

›
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ap...
Saturday, June 22, 2019

Balversa (erdafitinib) Approved for Advanced Bladder Cancer

›
Balversa (erdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cance...
Friday, June 21, 2019

Mayzent Approved for Relapsing MS

›
Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis (MS)....
Wednesday, May 15, 2019

Mavenclad Approved for Multiple Sclerosis

›
In continuation of my update on Mavenclad ( cladribine)    Mavenclad ( cladribine ) tablets have been approved by the U.S. Foo...